Sarepta 提供关于 Srp-1003 的进展更新,这是一种用于肌强直性肌肉病 1 型的研究性 siRNA 治疗
Sarepta 提供关于 Srp-1003 的进展更新,这是一种用于肌强直性肌肉病 1 型的研究性 siRNA 治疗
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.